Enhanced expression of inducible nitric oxide synthase without vasodilator effect in chronically infected lungs
- 1 September 1999
- journal article
- research article
- Published by American Physiological Society in American Journal of Physiology-Lung Cellular and Molecular Physiology
- Vol. 277 (3) , L616-L627
- https://doi.org/10.1152/ajplung.1999.277.3.l616
Abstract
We hypothesized that abnormal ventilation-perfusion matching in chronically infected lungs was in part due to excess nitric oxide (NO) production after upregulation of inducible NO synthase (iNOS) expression. Rats were anesthetized and inoculated intratracheally withPseudomonas aeruginosa incorporated into agar beads (chronically infected) or with sterile agar beads (placebo inoculated) and killed 10–15 days later. Immunohistochemistry demonstrated increased expression of iNOS and reduced expression of endothelial NOS (eNOS) in chronically infected compared with placebo-inoculated or noninoculated lungs. In isolated lungs from chronically infected rats, NOS inhibition withNω-nitro-l-arginine methyl ester increased the mean perfusion pressure (14.4 ± 2.7 mmHg) significantly more than in the placebo-inoculated (4.8 ± 1.0 mmHg) or noninoculated (5.3 ± 0.8 mmHg) lungs (P < 0.01). Although the chronically infected lungs were more sensitive to NOS inhibition, further evidence suggested that the increased iNOS expression was not associated with enhanced iNOS activity. Selective inhibitors of iNOS did not produce an increase in vascular resistance similar to that produced by nonselective inhibitors. Accumulation of nitrate/nitrite in the perfusate of isolated lungs was unchanged by chronic infection. Thus although iNOS expression was increased in chronic pulmonary infection, iNOS activity in the intact lung was not. Nonetheless, endogenous NO production was essential to maintain normal vascular resistance in these lungs.Keywords
This publication has 30 references indexed in Scilit:
- Hypoxic pulmonary vasoconstriction is enhanced by inhibition of the synthesis of an endothelium derived relaxing factorPublished by Elsevier ,2004
- Reduced Endothelial Nitric Oxide Synthase Expression and Production in Human AtherosclerosisCirculation, 1998
- The inhibitory effects of mercaptoalkylguanidines on cyclo‐oxygenase activityBritish Journal of Pharmacology, 1997
- Differential regulation of the constitutive and inducible nitric oxide synthase mRNA by lipopolysacchride treatment in vivo in the ratCritical Care Medicine, 1996
- Nitric oxide synthase activity is elevated in inflammatory lung disease in humansEuropean Journal of Pharmacology, 1995
- Nitric oxide: mediator, murderer, and medicinePublished by Elsevier ,1994
- Metabolism and excretion of nitric oxide in humans. An experimental and clinical study.Circulation Research, 1993
- A Fluorometric Assay for the Measurement of Nitrite in Biological SamplesAnalytical Biochemistry, 1993
- Evidence for cytokine-inducible nitric oxide synthesis from L-arginine in patients receiving interleukin-2 therapy.Journal of Clinical Investigation, 1992
- Pulmonary Function and Response to Exercise in Cystic FibrosisArchives of Disease in Childhood, 1971